お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は小児用ワクチン市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは小児用ワクチンの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の小児用ワクチン市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは小児用ワクチンのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に小児用ワクチン市場を分類しています。本研究に含まれる主な企業は：GlaxoSmithCline、Merck、Sanofi、Bristol-Myers Squibb、Abbott Laboratories、Eli Lilly、Pfizer、F. Hoffmann-La Roche、Novo Nordisk

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Pneumococcal
    Varicella
    Combinations
    Poliovirus
    Hepatitis
    MMR
    Pediatric Hormones
    HIB
    Allergy and Respiratory vaccines
    Other Pediatric vaccines

用途別の市場セグメント：
    Age (0-3)
    Age (3-12)
    Age Above 12

本レポートの詳細内容
世界の小児用ワクチン市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、小児用ワクチンタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の小児用ワクチン収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の小児用ワクチン市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、小児用ワクチン市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

小児用ワクチンのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：小児用ワクチンのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：小児用ワクチンの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章小児用ワクチン企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：小児用ワクチンの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：小児用ワクチンの主要企業の概要を提供し、製品の説明と仕様、小児用ワクチンの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Paediatric Vaccine Market
The global Paediatric Vaccine market is projected to grow from US$ 22580 million in 2024 to US$ 31130 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Paediatric Vaccine market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Paediatric Vaccine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Paediatric Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Paediatric Vaccine revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Paediatric Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Paediatric Vaccine revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Pfizer, F. Hoffmann-La Roche and Novo Nordisk, etc.
Market Segmentation
By Company
    GlaxoSmithCline
    Merck
    Sanofi
    Bristol-Myers Squibb
    Abbott Laboratories
    Eli Lilly
    Pfizer
    F. Hoffmann-La Roche
    Novo Nordisk

Segment by Type
    Pneumococcal
    Varicella
    Combinations
    Poliovirus
    Hepatitis
    MMR
    Pediatric Hormones
    HIB
    Allergy and Respiratory vaccines
    Other Pediatric vaccines

Segment by Application
    Age (0-3)
    Age (3-12)
    Age Above 12

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Paediatric Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Paediatric Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Paediatric Vaccine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Paediatric Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Pneumococcal
    Table 3. Key Players of Varicella
    Table 4. Key Players of Combinations
    Table 5. Key Players of Poliovirus
    Table 6. Key Players of Hepatitis
    Table 7. Key Players of MMR
    Table 8. Key Players of Pediatric Hormones
    Table 9. Key Players of HIB
    Table 10. Key Players of Allergy and Respiratory vaccines
    Table 11. Key Players of Other Pediatric vaccines
    Table 12. Global Paediatric Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 13. Global Paediatric Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 14. Global Paediatric Vaccine Market Size by Region (2019-2024) & (US$ Million)
    Table 15. Global Paediatric Vaccine Market Share by Region (2019-2024)
    Table 16. Global Paediatric Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 17. Global Paediatric Vaccine Market Share by Region (2025-2030)
    Table 18. Paediatric Vaccine Market Trends
    Table 19. Paediatric Vaccine Market Drivers
    Table 20. Paediatric Vaccine Market Challenges
    Table 21. Paediatric Vaccine Market Restraints
    Table 22. Global Paediatric Vaccine Revenue by Players (2019-2024) & (US$ Million)
    Table 23. Global Paediatric Vaccine Revenue Share by Players (2019-2024)
    Table 24. Global Top Paediatric Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Vaccine as of 2023)
    Table 25. Global Paediatric Vaccine Industry Ranking 2022 VS 2023 VS 2024
    Table 26. Global 5 Largest Players Market Share by Paediatric Vaccine Revenue (CR5 and HHI) & (2019-2024)
    Table 27. Global Key Players of Paediatric Vaccine, Headquarters and Area Served
    Table 28. Global Key Players of Paediatric Vaccine, Product and Application
    Table 29. Global Key Players of Paediatric Vaccine, Product and Application
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Paediatric Vaccine Market Size by Type (2019-2024) & (US$ Million)
    Table 32. Global Paediatric Vaccine Revenue Market Share by Type (2019-2024)
    Table 33. Global Paediatric Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 34. Global Paediatric Vaccine Revenue Market Share by Type (2025-2030)
    Table 35. Global Paediatric Vaccine Market Size by Application (2019-2024) & (US$ Million)
    Table 36. Global Paediatric Vaccine Revenue Share by Application (2019-2024)
    Table 37. Global Paediatric Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 38. Global Paediatric Vaccine Revenue Share by Application (2025-2030)
    Table 39. North America Paediatric Vaccine Market Size by Type (2019-2024) & (US$ Million)
    Table 40. North America Paediatric Vaccine Market Size by Type (2025-2030) & (US$ Million)
    Table 41. North America Paediatric Vaccine Market Size by Application (2019-2024) & (US$ Million)
    Table 42. North America Paediatric Vaccine Market Size by Application (2025-2030) & (US$ Million)
    Table 43. North America Paediatric Vaccine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. North America Paediatric Vaccine Market Size by Country (2019-2024) & (US$ Million)
    Table 45. North America Paediatric Vaccine Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Europe Paediatric Vaccine Market Size by Type (2019-2024) & (US$ Million)
    Table 47. Europe Paediatric Vaccine Market Size by Type (2025-2030) & (US$ Million)
    Table 48. Europe Paediatric Vaccine Market Size by Application (2019-2024) & (US$ Million)
    Table 49. Europe Paediatric Vaccine Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Europe Paediatric Vaccine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 51. Europe Paediatric Vaccine Market Size by Country (2019-2024) & (US$ Million)
    Table 52. Europe Paediatric Vaccine Market Size by Country (2025-2030) & (US$ Million)
    Table 53. China Paediatric Vaccine Market Size by Type (2019-2024) & (US$ Million)
    Table 54. China Paediatric Vaccine Market Size by Type (2025-2030) & (US$ Million)
    Table 55. China Paediatric Vaccine Market Size by Application (2019-2024) & (US$ Million)
    Table 56. China Paediatric Vaccine Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Paediatric Vaccine Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Asia Paediatric Vaccine Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Asia Paediatric Vaccine Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Asia Paediatric Vaccine Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Asia Paediatric Vaccine Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Asia Paediatric Vaccine Market Size by Region (2019-2024) & (US$ Million)
    Table 63. Asia Paediatric Vaccine Market Size by Region (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Type (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Type (2025-2030) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Application (2019-2024) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Application (2025-2030) & (US$ Million)
    Table 68. Middle East, Africa, and Latin America Paediatric Vaccine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 69. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Country (2019-2024) & (US$ Million)
    Table 70. Middle East, Africa, and Latin America Paediatric Vaccine Market Size by Country (2025-2030) & (US$ Million)
    Table 71. GlaxoSmithCline Company Details
    Table 72. GlaxoSmithCline Business Overview
    Table 73. GlaxoSmithCline Paediatric Vaccine Product
    Table 74. GlaxoSmithCline Revenue in Paediatric Vaccine Business (2019-2024) & (US$ Million)
    Table 75. GlaxoSmithCline Recent Developments
    Table 76. Merck Company Details
    Table 77. Merck Business Overview
    Table 78. Merck Paediatric Vaccine Product
    Table 79. Merck Revenue in Paediatric Vaccine Business (2019-2024) & (US$ Million)
    Table 80. Merck Recent Developments
    Table 81. Sanofi Company Details
    Table 82. Sanofi Business Overview
    Table 83. Sanofi Paediatric Vaccine Product
    Table 84. Sanofi Revenue in Paediatric Vaccine Business (2019-2024) & (US$ Million)
    Table 85. Sanofi Recent Developments
    Table 86. Bristol-Myers Squibb Company Details
    Table 87. Bristol-Myers Squibb Business Overview
    Table 88. Bristol-Myers Squibb Paediatric Vaccine Product
    Table 89. Bristol-Myers Squibb Revenue in Paediatric Vaccine Business (2019-2024) & (US$ Million)
    Table 90. Bristol-Myers Squibb Recent Developments
    Table 91. Abbott Laboratories Company Details
    Table 92. Abbott Laboratories Business Overview
    Table 93. Abbott Laboratories Paediatric Vaccine Product
    Table 94. Abbott Laboratories Revenue in Paediatric Vaccine Business (2019-2024) & (US$ Million)
    Table 95. Abbott Laboratories Recent Developments
    Table 96. Eli Lilly Company Details
    Table 97. Eli Lilly Business Overview
    Table 98. Eli Lilly Paediatric Vaccine Product
    Table 99. Eli Lilly Revenue in Paediatric Vaccine Business (2019-2024) & (US$ Million)
    Table 100. Eli Lilly Recent Developments
    Table 101. Pfizer Company Details
    Table 102. Pfizer Business Overview
    Table 103. Pfizer Paediatric Vaccine Product
    Table 104. Pfizer Revenue in Paediatric Vaccine Business (2019-2024) & (US$ Million)
    Table 105. Pfizer Recent Developments
    Table 106. F. Hoffmann-La Roche Company Details
    Table 107. F. Hoffmann-La Roche Business Overview
    Table 108. F. Hoffmann-La Roche Paediatric Vaccine Product
    Table 109. F. Hoffmann-La Roche Revenue in Paediatric Vaccine Business (2019-2024) & (US$ Million)
    Table 110. F. Hoffmann-La Roche Recent Developments
    Table 111. Novo Nordisk Company Details
    Table 112. Novo Nordisk Business Overview
    Table 113. Novo Nordisk Paediatric Vaccine Product
    Table 114. Novo Nordisk Revenue in Paediatric Vaccine Business (2019-2024) & (US$ Million)
    Table 115. Novo Nordisk Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Paediatric Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Paediatric Vaccine Market Share by Type: 2023 VS 2030
    Figure 3. Pneumococcal Features
    Figure 4. Varicella Features
    Figure 5. Combinations Features
    Figure 6. Poliovirus Features
    Figure 7. Hepatitis Features
    Figure 8. MMR Features
    Figure 9. Pediatric Hormones Features
    Figure 10. HIB Features
    Figure 11. Allergy and Respiratory vaccines Features
    Figure 12. Other Pediatric vaccines Features
    Figure 13. Global Paediatric Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 14. Global Paediatric Vaccine Market Share by Application: 2023 VS 2030
    Figure 15. Age (0-3) Case Studies
    Figure 16. Age (3-12) Case Studies
    Figure 17. Age Above 12 Case Studies
    Figure 18. Paediatric Vaccine Report Years Considered
    Figure 19. Global Paediatric Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 20. Global Paediatric Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 21. Global Paediatric Vaccine Market Share by Region: 2023 VS 2030
    Figure 22. Global Paediatric Vaccine Market Share by Players in 2023
    Figure 23. Global Top Paediatric Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Vaccine as of 2023)
    Figure 24. The Top 10 and 5 Players Market Share by Paediatric Vaccine Revenue in 2023
    Figure 25. North America Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. North America Paediatric Vaccine Market Share by Type (2019-2030)
    Figure 27. North America Paediatric Vaccine Market Share by Application (2019-2030)
    Figure 28. North America Paediatric Vaccine Market Share by Country (2019-2030)
    Figure 29. United States Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Canada Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Europe Paediatric Vaccine Market Size YoY (2019-2030) & (US$ Million)
    Figure 32. Europe Paediatric Vaccine Market Share by Type (2019-2030)
    Figure 33. Europe Paediatric Vaccine Market Share by Application (2019-2030)
    Figure 34. Europe Paediatric Vaccine Market Share by Country (2019-2030)
    Figure 35. Germany Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. France Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. U.K. Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Italy Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Russia Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Nordic Countries Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Paediatric Vaccine Market Size YoY (2019-2030) & (US$ Million)
    Figure 42. China Paediatric Vaccine Market Share by Type (2019-2030)
    Figure 43. China Paediatric Vaccine Market Share by Application (2019-2030)
    Figure 44. Asia Paediatric Vaccine Market Size YoY (2019-2030) & (US$ Million)
    Figure 45. Asia Paediatric Vaccine Market Share by Type (2019-2030)
    Figure 46. Asia Paediatric Vaccine Market Share by Application (2019-2030)
    Figure 47. Asia Paediatric Vaccine Market Share by Region (2019-2030)
    Figure 48. Japan Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. South Korea Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. China Taiwan Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Southeast Asia Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. India Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Australia Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Middle East, Africa, and Latin America Paediatric Vaccine Market Size YoY (2019-2030) & (US$ Million)
    Figure 55. Middle East, Africa, and Latin America Paediatric Vaccine Market Share by Type (2019-2030)
    Figure 56. Middle East, Africa, and Latin America Paediatric Vaccine Market Share by Application (2019-2030)
    Figure 57. Middle East, Africa, and Latin America Paediatric Vaccine Market Share by Country (2019-2030)
    Figure 58. Brazil Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Mexico Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Turkey Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Saudi Arabia Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Israel Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 63. GCC Countries Paediatric Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 64. GlaxoSmithCline Revenue Growth Rate in Paediatric Vaccine Business (2019-2024)
    Figure 65. Merck Revenue Growth Rate in Paediatric Vaccine Business (2019-2024)
    Figure 66. Sanofi Revenue Growth Rate in Paediatric Vaccine Business (2019-2024)
    Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Paediatric Vaccine Business (2019-2024)
    Figure 68. Abbott Laboratories Revenue Growth Rate in Paediatric Vaccine Business (2019-2024)
    Figure 69. Eli Lilly Revenue Growth Rate in Paediatric Vaccine Business (2019-2024)
    Figure 70. Pfizer Revenue Growth Rate in Paediatric Vaccine Business (2019-2024)
    Figure 71. F. Hoffmann-La Roche Revenue Growth Rate in Paediatric Vaccine Business (2019-2024)
    Figure 72. Novo Nordisk Revenue Growth Rate in Paediatric Vaccine Business (2019-2024)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed